SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company’s lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tu... SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company’s lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK’s WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.48 | 19.4993412385 | 7.59 | 9.25 | 7.46 | 8670987 | 8.33516402 | CS |
| 4 | 0.94 | 11.5621156212 | 8.13 | 9.51 | 7.07 | 8419806 | 8.44942683 | CS |
| 12 | 4.74 | 109.468822171 | 4.33 | 9.51 | 4.02 | 7413058 | 7.06102067 | CS |
| 26 | 6.29 | 226.258992806 | 2.78 | 9.51 | 2.6 | 8305660 | 5.47048766 | CS |
| 52 | 7.35 | 427.325581395 | 1.72 | 9.51 | 1.39 | 5903832 | 4.35679261 | CS |
| 156 | 7.38 | 436.686390533 | 1.69 | 9.51 | 0.4986 | 2763103 | 3.47569768 | CS |
| 260 | -4.41 | -32.7151335312 | 13.48 | 15.0789 | 0.4986 | 1760613 | 3.56053053 | CS |
DFRAI
3日前
DFRAI
4日前
powerwalker
4日前
DFRAI
4日前
jdheart101
2週前
norisknorewards
2週前
jdheart101
2週前
norisknorewards
2週前
jdheart101
2週前
jdheart101
2週前
norisknorewards
3週前
jdheart101
3週前
powerwalker
3週前
jdheart101
1月前
VanGan
1月前
TTsr
1月前
Hoskuld
1月前
Hoskuld
1月前
nsomniyak
1月前
jdheart101
1月前
jdheart101
1月前
jdheart101
1月前
Hoskuld
1月前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。